GlassScriptPhysician profile
Janelle Perrone
NPI 1982950424
$6,670.01
in general payments reported to CMS, 2019-2025
41 companies · $925 in 2025
The $925 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $740 · 2020: $598 · 2021: $772 · 2022: $1,923 · 2023: $965 · 2024: $747 · 2025: $925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,636.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,089.35 | 2019-2023 | Da Vinci Surgical System |
| Novo Nordisk INC | $512.47 | 2019-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $479.26 | 2019-2025 | |
| Abbvie INC. | $470.71 | 2019-2023 | |
| Biogen, INC. | $382.58 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $373.79 | 2020-2025 | Slynd |
| Pfizer INC. | $367.34 | 2021-2024 | |
| Astellas Pharma US INC | $321.39 | 2021-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $239.85 | 2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $212.47 | 2019-2025 | Gardasil 9, Gardasil, Capvaxive |
| Mayne Pharma Commercial LLC | $210.25 | 2022-2025 | |
| Amgen INC. | $204.34 | 2019-2025 | Evenity, Prolia |
| Millicent US INC | $182.52 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Applied Medical Resources Corporation | $168.59 | 2022 | |
| Evofem Biosciences, INC. | $143.56 | 2021-2024 | Phexxi |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $125.41 | 2019-2023 | Summit Doppler |
| Allergan, INC. | $117.15 | 2019-2020 | |
| Lupin INC. | $106.22 | 2019-2020 | |
| Organon LLC | $106.13 | 2021-2024 | Nexplanon |
| Shield Therapeutics INC | $91.47 | 2022-2024 | Accrufer |
| Exact Sciences Corporation | $88.83 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Avanos Medical | $87.97 | 2019-2023 | On-Q* Pump and Accessories |
| Agile Therapeutics, INC. | $81.54 | 2021-2023 | Twirla |
| Therapeuticsmd, INC. | $80.14 | 2020-2022 | |
| Gynesonics, INC. | $60.54 | 2022 | |
| Radius Health, INC. | $44.24 | 2019-2020 | |
| Avion Pharmaceuticals | $43.63 | 2020-2022 | |
| Boston Scientific Corporation | $41.98 | 2020-2022 | |
| Acessa Health INC. | $26.70 | 2020 | |
| Duchesnay USA Incorporated | $23.60 | 2019 | |
| Dexcom, INC. | $22.27 | 2024 | Dexcom G6 Transmitter |
| Ascend Therapeutics US, LLC | $21.72 | 2019 | |
| Davol INC. | $21.52 | 2021 | |
| Baxter Healthcare | $20.75 | 2020 | |
| Amag Pharmaceuticals, INC. | $20.10 | 2019 | |
| Smith+Nephew, INC. | $17.94 | 2019 | |
| Currax Pharmaceuticals LLC | $15.49 | 2023 | Contrave |
| Minerva Surgical, INC | $13.68 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $13.61 | 2019 | |
| Genentech USA, INC. | $12.23 | 2019 | |
| Channel Medsystems, INC. | $6.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janelle Perrone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.